Characteristics and Treatment Patterns of Patients With Sickle Cell Disease in Globin Research Network for Data and Discovery Registry
NCT06662812 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1665
Last updated 2024-10-29
Summary
This was a retrospective observational cohort study. This study was a secondary analysis of individuals with sickle cell disease (SCD) enrolled in the GRNDaD registry.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Novartis Pharmaceuticals · Novartis Pharmaceuticals
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-10-06
- Primary Completion
- 2023-12-01
- Completion
- 2023-12-01
Countries
- United States
Study Locations
More Related Trials
-
Biological, Genetic and Environmental Involved in the Complications of Sickle Cell Disease
NCT04205123 ·Status: UNKNOWN
-
Relationship Between Biological Phenotype, Clinical Severity of Sickle Cell Disease, and Blood Coagulation
NCT06619093 ·Status: NOT_YET_RECRUITING
-
Dense Red Blood Cells in Sickle Cell Children
NCT02887118 ·Status: TERMINATED
-
Study of a Red Blood Cell Deformability Parameter in Patients With Sickle Cell Disease
NCT03977532 ·Status: COMPLETED ·Phase: NA
-
Neurovascular Determinants of Cognitive Function in Adults With Sickle Cell Disease
NCT02946905 ·Status: COMPLETED
-
Establishing a Repository of Blood and DNA Samples From People With Sickle Cell Disease (Comprehensive Sickle Cell Centers Collaborative Genotype-Phenotype Database and Sample Repository)
NCT00528203 ·Status: TERMINATED
-
Cooperative Study of The Clinical Course of Sickle Cell Disease
NCT00005277 ·Status: COMPLETED
-
Blood Sampling for Research Related to Sickle Cell Disease
NCT00542230 ·Status: RECRUITING
-
Transfusion in Sickle Cell Disease: Risk Factors for Alloimmunization
NCT03405402 ·Status: COMPLETED ·Phase: NA
-
Improving Sickle Cell Disease (SCD) Care Using Web-based Guidelines
NCT03037021 ·Status: COMPLETED
-
Sickle Cell Disease: Targeting Alloantibody Formation Reduction; Risk Factors, and Genetics
NCT03288012 ·Status: UNKNOWN
-
Investigation of Selected Patient Groups From The Cooperative Study of Sickle Cell Disease
NCT00005300 ·Status: COMPLETED
-
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Oral GSK4172239D Compared With Placebo in Sickle Cell Disease Participants Aged 18 to 50 Years
NCT05660265 ·Status: TERMINATED ·Phase: PHASE1
-
Carbon Monoxide Levels and Sickle Cell Disease Severity
NCT01547793 ·Status: COMPLETED
-
Observational Study to Deeply Phenotype Major Organs in Sickle Cell Disease After Curative Therapies
NCT05213572 ·Status: RECRUITING
-
Effect of NUV001 Supplementation in Patients Suffering From Sickle Cell Disease (SCD)
NCT05789355 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
GenoMed4ALL: Improving SCD Classification and Prognosis by AI
NCT06019208 ·Status: UNKNOWN
-
Patient Characteristics and Treatment Patterns From Early Crizanlizumab Use in Real-world Setting: Preliminary Analysis From Select Sickle Cell Centers
NCT05833022 ·Status: COMPLETED
-
Sickle Cell Disease: A Retrospective Chart Review
NCT01441375 ·Status: COMPLETED
-
A Study to Learn About Sickle Cell Disease In Adult Patients
NCT05407805 ·Status: COMPLETED
-
Nano-rheological Biomarkers for Patients With Sickle Cell Disease (SCD) Versus Control Subjects (Other Constitutional Red Blood Cell Diseases and Healthy Subjects)
NCT05530239 ·Status: NOT_YET_RECRUITING
-
Losartan for Sickle Cell Kidney Disease
NCT01989078 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Real World Patient Characteristics and Treatment Patterns From Crizanlizumab Use: Preliminary Analysis From Select Sickle Cell Centers
NCT06662825 ·Status: COMPLETED
-
Plasma DNA and Vascular Remodelling in Patients With Sickle Cell Disease
NCT02721472 ·Status: COMPLETED ·Phase: NA
-
The Influence of micro-and Macro Vascular Dysfunction on Clinical Severity in Adults With Sickle Cell Anemia (SS) and Sickle Cell Hemoglobin C Disease (SC)
NCT07277023 ·Status: COMPLETED ·Phase: NA